| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 16,233 | 27,517 | 50,605 | 76,020 | | Cost of Revenue | 14,474 | 19,491 | 32,159 | 45,023 | | | Gross Profit | 1,759 | 8,026 | 18,446 | 30,997 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 29,343 | 4,930 | 5,188 | 9,418 | | Non Recurring | 21,247 |
-
|
-
| 24,328 | | Others | 11,664 | 11,962 | 12,526 | 13,067 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (39,248) | (8,866) | 732 | (15,816) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (4,509) | 423 | (565) | (14,824) | | Earnings Before Interest And Taxes | (66,275) | (9,412) | 579 | (31,308) | | Interest Expense | 1,494 | 1,855 | 2,299 | 815 | | Income Before Tax | (67,769) | (11,267) | (1,720) | (32,123) | | Income Tax Expense | (25,116) | (4,108) | (11) | (12,309) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (47,340) | (7,159) | (1,709) | (19,814) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (42,653) | (7,159) | (1,709) | (19,814) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($42,653) | ($7,159) | ($1,709) | ($19,814) |
|
0.26% Nasdaq 
0.18 (3.35%) 
Income Statement
